Update shared on01 Aug 2025
Fair value Decreased 47%The sharp decrease in Beyond Air's future P/E ratio indicates revised expectations of slower earnings growth, contributing to a substantial reduction in the consensus analyst price target from $36.60 to $19.40.
What's in the News
- Beyond Air secured a national group purchasing agreement with Premier, Inc. for its LungFit PH system and NO2 Smart Filters, enhancing distribution and pricing access for Premier members.
- The company approved a 1-for-20 reverse stock split effective July 14, 2025.
- Auditors expressed substantial doubt about Beyond Air’s ability to continue as a going concern in the latest 10-K filing.
- Fiscal guidance sets revenue expectations at $1.7 million for the June 2025 quarter and $12–16 million for the year ending March 2025.
- A PMA supplement application for the next-generation LungFit PH II, a smaller and transport-ready nitric oxide generator, was submitted to the FDA.
Valuation Changes
Summary of Valuation Changes for Beyond Air
- The Consensus Analyst Price Target has significantly fallen from $36.60 to $19.40.
- The Future P/E for Beyond Air has significantly fallen from 38.06x to 20.22x.
- The Discount Rate for Beyond Air remained effectively unchanged, moving only marginally from 8.66% to 8.81%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.